Allocations
IQ Capital has led a GBP 5.5 million series A funding round in CyberSmart, which helps small to medium-sized businesses combat cyber-attacks.
The fresh capital will be used to fund CyberSmart’s growth, which has seen an increase in demand with a revenue increase of 300 per cent over the past 12 months, as the lockdown accelerated the use of its cloud-based technology, according to the company.
“We are delighted to have closed our Series A funding round with GBP 5.5 million to fund our next stage of growth. Our investors have seen that we have built a great technology and
iOnctura SA, a clinical stage biopharmaceutical company, developing a pipeline of next generation molecules targeting cancer and fibrosis, has raised an additional EUR5.1 million bringing its total Series A financing to EUR20.1 million. New investor 3B Future Health Fund, previously known as Helsinn Investment Fund, SICAR joins the existing blue chip investor syndicate of M Ventures, INKEF Capital, VI Partners, and Schroder Adveq, which all participated in the extension.
The funding will enable iOnctura to accelerate development of its next generation dual immune and tumour targeting therapies. Data emerging from early clinical evaluation of its lead molecule IOA-244, a highly selective
Mid-market private equity investor LDC says there are signs transaction activity had started to rebound as more companies looked beyond the impact of the pandemic to long-term growth and diversification strategies.In a half-year update, the firm announced it had backed a total of 18 investments in the first half of 2020. The majority completed since the onset of the pandemic, with momentum increasing as eight deals closed in the past four weeks alone, and its pipeline for the second half of the year building quickly.
LDC, which plans to invest GBP1.2 billion of capital over the next three years, says
Munich Private Equity Partners (MPEP) has closed its third private equity program at EUR 162 million with renowned international investors. The original target for MPEP III was EUR100 million.
MPEP launches a new private equity program approximately every 18 months. Benefiting from the relationship with its anchor investor, the mid-cap buyout specialist is able to build up substantial parts of the fund portfolios before it begins active fundraising with institutional investors. Therefore, potential investors receive favourable visibility on the manager quality and expected portfolio composition, consequently the blind pool risk typically associated with such investments is substantially reduced compared to
TrueBridge Capital Partners has closed its sixth venture capital fund-of-funds, TrueBridge Capital Partners Fund VI, with USD600 million in capital from LPs.
Investors into TrueBridge Fund VI include new and existing global LPs, including foundations and endowments, pension funds, family offices, as well as high net worth individuals.
With this latest fund, TrueBridge now manages over USD3.3 billion in assets. “Today’s global economic environment is one with a truly unprecedented level of uncertainty. Now more than ever, there is a tremendous need and opportunity to connect venture capitalists and entrepreneurs as they pioneer new technologies to better navigate our evolving
Kester Capital’s (Kester) portfolio company Frontier Medical, has sold its Infection Prevention business in a carve-out to Vernacare, backed by HIG Capital. The deal includes the brands Sharpsafe, Clinisafe and eXchange. Terms of the transaction have not been disclosed.
The exited businesses are industry-leaders in the Infection Prevention market providing an extensive range of sharps and clinical waste disposal solutions. Sharpsafe was the world’s first purpose-designed plastic sharps container. With a customer base across the UK and Europe, the business operates from its site in Blackwood, Wales.
Frontier’s core division, Frontier Therapeutics, a leading provider of differentiated Skin and
The EQT VII fund (EQT VII) has agreed to sell IFS AB (IFS) to the successor funds EQT VIII and EQT IX, and global growth private equity firm, TA Associates, which becomes a minority partner at a transaction value in excess of EUR3 billion.
Antares served as sole lead arranger and sole lender on USD65 million in senior secured credit facilities to support the acquisition of Metal Era by GreyLion Capital.Founded in 1980 in Waukesha, WI, Metal Era is a manufacturer of high-performance roofing products focused on metal edge and ventilation solutions for commercial, institutional and industrial buildings.
“We appreciate Antares’ speed, flexibility and ability to speak for the full facility size,” says John McKee, Partner at GreyLion Capital. “They showed an impressive ability to commit and close in the midst of the fallout from Covid-19.”
“We are pleased to support GreyLion as they
Roslin Technologies, the UK’s specialist AgriTech venture builder, is embarking on a GBP50 million second round capital raise, valuing the Edinburgh-based company at more than GBP55 million. The four-year-old business, which partners closely with the Roslin Institute, creator of Dolly the Sheep, will use the funds to invest in a wide range of cutting-edge AgriTech initiatives and build valuable relationships through its growing number of portfolio companies. The investment round will be led by Milltrust International LLP and JBI Equity, two of the world’s leading AgriTech advisors, and both founding investors in the company.
Founded to help turn the scientific
Loss adjusting and claims management specialist GHG Limited near Southampton has funded its primary buy-out by securing a GBP7 million equity investment from YFM Equity Partners (YFM). The deal, with a total value of GBP17 million, is the first from the PE house’s GBP80 million Buyout Fund II and marks the second investment made by YFM since the Coronavirus pandemic began, following on from its investment into vehicle safety systems business ISS.
The buyout was led by GHG managing director Austin Snelgrove (pictured above left) who, for the last three years, has been working alongside founder Graham High (above right), as
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
